Anaemia and red blood cell transfusion in women with placenta accreta spectrum: an analysis of 38,060 cases.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
29 Feb 2024
29 Feb 2024
Historique:
received:
19
11
2023
accepted:
24
02
2024
medline:
1
3
2024
pubmed:
1
3
2024
entrez:
29
2
2024
Statut:
epublish
Résumé
Placenta accreta spectrum (PAS) has become a significant life-threatening issue due to its increased incidence and associated morbidity and mortality. Pregnancy is often associated with states of anaemia, and severe maternal haemorrhage represents a major risk factor for red blood cell (RBC) transfusion. The present study retrospectively analyzed the prevalence of anaemia, transfusion requirements and outcome in women with PAS. Using data from the German Statistical Office pregnant patients with deliveries hospitalized between January 2012 and December 2021 were included. Primary outcome was the prevalence of anemia and administration of RBCs. Secondary outcome were complications in women with PAS who received RBC transfusion. In total 6,493,606 pregnant women were analyzed, of which 38,060 (0.59%) were diagnosed with PAS. The rate of anaemia during pregnancy (60.36 vs. 23.25%; p < 0.0001), postpartum haemorrhage (47.08 vs. 4.41%; p < 0.0001) and RBC transfusion rate (14.68% vs. 0.72%; p < 0.0001) were higher in women with PAS compared to women without PAS. Women with PAS who had bleeding and transfusion experienced significantly more peripartum complications than those who did not. A multiple logistic regression revealed that the probability for RBC transfusion in all pregnant women was positively associated with anaemia (OR 21.96 (95% CI 21.36-22.58)). In women with PAS, RBC transfusion was positively associated with the presence of renal failure (OR 11.27 (95% CI 9.35-13.57)) and congestive heart failure (OR 6.02 (95% CI (5.2-7.07)). Early anaemia management prior to delivery as well as blood conservation strategies are crucial in women diagnosed with PAS.
Identifiants
pubmed: 38424178
doi: 10.1038/s41598-024-55531-6
pii: 10.1038/s41598-024-55531-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4999Informations de copyright
© 2024. The Author(s).
Références
Wu, S., Kocherginsky, M. & Hibbard, J. U. Abnormal placentation: Twenty-year analysis. Am. J. Obstet. Gynecol. 192(5), 1458–1461 (2005).
doi: 10.1016/j.ajog.2004.12.074
pubmed: 15902137
Jauniaux, E. et al. Prevalence and main outcomes of placenta accreta spectrum: A systematic review and meta-analysis. Am. J. Obstet. Gynecol. 221(3), 208–218 (2019).
doi: 10.1016/j.ajog.2019.01.233
pubmed: 30716286
Bluth, A. et al. Placenta accreta spectrum disorders-experience of management in a German tertiary perinatal centre. Arch. Gynecol. Obstet. 303(6), 1451–1460 (2021).
doi: 10.1007/s00404-020-05875-x
pubmed: 33284419
Palacios-Jaraquemada, J. M. Diagnosis and management of placenta accreta. Best Pract. Res. Clin. Obstet. Gynaecol. 22(6), 1133–48 (2008).
doi: 10.1016/j.bpobgyn.2008.08.003
pubmed: 18815074
Wright, J. D. et al. Predictors of massive blood loss in women with placenta accreta. Am. J. Obstet. Gynecol. 205(1), 38.e1–6 (2011).
doi: 10.1016/j.ajog.2011.01.040
pubmed: 21419387
Miller, S. E. et al. Red blood cell transfusion in patients with placenta accreta spectrum: A systematic review and meta-analysis. Obstet. Gynecol. 141(1), 49–58 (2023).
doi: 10.1097/AOG.0000000000004976
pubmed: 36701609
Gatta, L. A. et al. Transfusion requirements with hybrid management of placenta accreta spectrum incorporating targeted embolization and a selective use of delayed hysterectomy. Am. J. Perinatol. 29(14), 1503–1513 (2022).
doi: 10.1055/s-0042-1754321
pubmed: 35973741
pmcid: 10035416
Enste, R. et al. Placenta Accreta Spectrum Part II: Hemostatic considerations based on an extended review of the literature. J. Perinat. Med. 51(4), 455–467 (2023).
doi: 10.1515/jpm-2022-0233
pubmed: 36181735
Shamshirsaz, A. A. et al. Coagulopathy in surgical management of placenta accreta spectrum. Eur. J. Obstet. Gynecol. Reprod. Biol. 237, 126–130 (2019).
doi: 10.1016/j.ejogrb.2019.04.026
pubmed: 31029971
McLean, E. et al. Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993–2005. Public Health Nutr. 12(4), 444–454 (2009).
doi: 10.1017/S1368980008002401
pubmed: 18498676
Butwick, A. J. & McDonnell, N. Antepartum and postpartum anemia: A narrative review. Int. J. Obstet. Anesth. 47, 102985 (2021).
doi: 10.1016/j.ijoa.2021.102985
pubmed: 33893005
Breymann, C. Iron deficiency anemia in pregnancy. Semin. Hematol. 52(4), 339–347 (2015).
doi: 10.1053/j.seminhematol.2015.07.003
pubmed: 26404445
Muñoz, M. et al. Patient blood management in obstetrics: Management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. Transfus Med. 28(1), 22–39 (2018).
doi: 10.1111/tme.12443
pubmed: 28722245
Statistische Ämter des Bundes und der Länder (DESTATIS). Fallpauschalenbezogene Krankenhausstatistik (DRG-Statistik) 2005–2021. https://www.forschungsdatenzentrum.de/de/10-21242-23141-2020-00-00-1-1-0 . (2023).
Schlembach D.. Postpartum haemorrhage diagnosis and treatment. Guideline of the DGGG, OEGGG and SGGG. https://register.awmf.org/assets/guidelines/015-063l_S2k_Peripartale_Blutungen_Diagnostik_Therapie_PPH_2022-09_2.pdf . (2022).
Rath, W. Erkrankungen der Mutter in der Schwangerschaft/schwangerschaftsinduzierte Erkrankungen (II) (Geburtshilfe und Perinatalmedizin, 2010).
doi: 10.1055/b-0034-86576
Bailit, J. L. et al. Morbidly adherent placenta treatments and outcomes. Obstet. Gynecol. 125(3), 683–689 (2015).
doi: 10.1097/AOG.0000000000000680
pubmed: 25730233
pmcid: 4347990
Esakoff, T. F. et al. Diagnosis and morbidity of placenta accreta. Ultrasound Obstet. Gynecol. 37(3), 324–327 (2011).
doi: 10.1002/uog.8827
pubmed: 20812377
Sumigama, S. et al. Placenta previa increta/percreta in Japan: A retrospective study of ultrasound findings, management and clinical course. J. Obstet. Gynaecol. Res. 33(5), 606–611 (2007).
doi: 10.1111/j.1447-0756.2007.00619.x
pubmed: 17845316
Morlando, M. & Collins, S. Placenta accreta spectrum disorders: Challenges, risks, and management strategies. Int. J. Womens Health 12, 1033–1045 (2020).
doi: 10.2147/IJWH.S224191
pubmed: 33204176
pmcid: 7667500
Usta, I. M. et al. Placenta previa-accreta: Risk factors and complications. Am. J. Obstet. Gynecol. 193(3 Pt 2), 1045–1049 (2005).
doi: 10.1016/j.ajog.2005.06.037
pubmed: 16157109
Hania, A. et al. Placenta accreta spectrum: A 2-year retrospective observational study. Irish Med. J. 115(7), 629 (2022).
Triphaus, C. et al. Effectiveness of preoperative iron supplementation in major surgical patients with iron deficiency: A prospective observational study. Ann. Surg. 274(3), e212–e219 (2021).
doi: 10.1097/SLA.0000000000003643
pubmed: 31939751
Neef, V. et al. Use of cell salvage in obstetrics in Germany: Analysis of national database of 305 610 cases with peripartum haemorrhage. Br. J. Anaesth. https://doi.org/10.1016/j.bja.2023.12.014 (2024).
doi: 10.1016/j.bja.2023.12.014
pubmed: 38267339
Sentilhes, L. et al. Tranexamic acid for the prevention of blood loss after cesarean delivery. N. Engl. J. Med. 384(17), 1623–1634 (2021).
doi: 10.1056/NEJMoa2028788
pubmed: 33913639
Benson, A. E. et al. The incidence, complications, and treatment of iron deficiency in pregnancy. Eur. J. Haematol. 109(6), 633–642 (2022).
doi: 10.1111/ejh.13870
pubmed: 36153674
pmcid: 9669178
Smith, C. et al. Maternal and perinatal morbidity and mortality associated with anemia in pregnancy. Obstet. Gynecol. 134(6), 1234–1244 (2019).
doi: 10.1097/AOG.0000000000003557
pubmed: 31764734
pmcid: 6882541
Brabin, B. J., Hakimi, M. & Pelletier, D. An analysis of anemia and pregnancy-related maternal mortality. J. Nutr. 131(2), 604S-615S (2001).
doi: 10.1093/jn/131.2.604S
pubmed: 11160593
National institute for Heath and Care Escellence (NICE). Antenatal Care. https://www.nice.org.uk/guidance/ng201/resources/antenatal-care-pdf-66143709695941 . (2021).
The American College of Obstetricians and Gynecologists (ACOG). Obstetric Care Consensus- Placenta accreta spectrum. https://www.acog.org/-/media/project/acog/acogorg/clinical/files/obstetric-care-consensus/articles/2018/12/placenta-accreta-spectrum.pdf . (2018).
Teichman, J. et al. Suboptimal iron deficiency screening in pregnancy and the impact of socioeconomic status in a high-resource setting. Blood Adv. 5(22), 4666–4673 (2021).
doi: 10.1182/bloodadvances.2021004352
pubmed: 34459878
pmcid: 8759118
Surbek, D. et al. Patient blood management (PBM) in pregnancy and childbirth: Literature review and expert opinion. Arch. Gynecol. Obstet. 301(2), 627–641 (2020).
doi: 10.1007/s00404-019-05374-8
pubmed: 31728665
Muñoz, M. et al. Patient blood management in obstetrics: Prevention and treatment of postpartum haemorrhage. A NATA consensus statement. Blood Transfus 17(2), 112–136 (2019).
pubmed: 30865585
pmcid: 6476742
Tyree, P. T., Lind, B. K. & Lafferty, W. E. Challenges of using medical insurance claims data for utilization analysis. Am. J. Med. Qual. 21(4), 269–275 (2006).
doi: 10.1177/1062860606288774
pubmed: 16849784
pmcid: 1533763